38 research outputs found

    The Distribution of Metallic Atoms in Two-Component Glasses

    No full text

    Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid

    No full text
    Boronic acids have been typecast as moieties for covalent complexation and are employed only rarely as agents for non-covalent recognition. By exploiting the profuse ability of a boronic acid group to form hydrogen bonds, we have developed an inhibitor of HIV-1 protease with extraordinary affinity. Specifically, we find that replacing an aniline moiety in darunavir with a phenylboronic acid leads to 20-fold greater affinity for the protease. X-ray crystallography demonstrates that the boronic acid group participates in three hydrogen bonds, more than the amino group of darunavir or any other analog. Importantly, the boronic acid maintains its hydrogen bonds and its affinity for the drug-resistant D30N variant of HIV-1 protease. The BOH路路路OC hydrogen bonds between the boronic acid hydroxy group and Asp30 (or Asn30) of the protease are short (rO路路路O = 2.2 脜), and density functional theory analysis reveals a high degree of covalency. These data highlight the utility of boronic acids as versatile functional groups in the design of small-molecule ligands. Keywords: peptides and proteins; crystal structure; inhibitors; noncovalent interactions; functional groupsNational Institutes of Health (U.S.) (Grant T32 GM008349)National Institutes of Health (U.S.) (Grant R01 GM044783)National Science Foundation (U.S.) (Grant MCB 1518160
    corecore